Kohjin Bio Co., Ltd. (TYO:177A)
Japan · Delayed Price · Currency is JPY 885.00
0.00 (0.00%)
Aug 6, 2026, 9:00 AM JST
Kohjin Bio Market Cap
Kohjin Bio has a market cap or net worth of 4.52 billion as of August 5, 2026. Its market cap has decreased by -49.94% in one year.
Market Cap
4.52B
Enterprise Value
4.23B
Revenue
4.94B
Ranking
n/a
PE Ratio
18.02
Stock Price
885.00
ChartMarket Cap Chart
Since April 25, 2024, Kohjin Bio's market cap has decreased from 11.89B to 4.52B, a decrease of -61.94%. That is a compound annual growth rate of -34.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 4.52B | -40.56% |
| Dec 30, 2025 | 7.61B | -11.16% |
| Dec 30, 2024 | 8.57B | -27.92% |
| Apr 25, 2024 | 11.89B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chordia Therapeutics | 6.03B |
| Noile-Immune Biotech | 5.90B |
| PRISM BioLab Co.,LTD | 5.80B |
| Soiken Holdings | 5.60B |
| Chiome Bioscience | 5.45B |
| Cyfuse Biomedical K.K. | 5.06B |
| TMS Co., Ltd. | 4.51B |
| D. Western Therapeutics Institute | 4.31B |